OS Benefit With Abemaciclib for HR-positive/HER2-Negative Advanced Breast Cancer
Results from the second interim analysis of MONARCH 3 show that overall survival is numerically...
Read MoreSep 14, 2022
Results from the second interim analysis of MONARCH 3 show that overall survival is numerically...
Read MoreSep 14, 2022
Addition of maintenance olaparib to bevacizumab provides a clinically meaningful overall survival...
Read MoreSep 14, 2022
MONDAY, Sept. 12, 2022 (HealthDay News) — The quantitative segmentation algorithm (QuantCRC)...
Read MoreSep 14, 2022
MONDAY, Sept. 12, 2022 (HealthDay News) — A decision-referral approach could leverage the...
Read MoreSep 14, 2022
MONDAY, Sept. 12, 2022 (HealthDay News) — Telemedicine and in-person diagnoses of new...
Read MoreSep 14, 2022
MONDAY, Sept. 12, 2022 (HealthDay News) — Fifty-one percent of patients receiving...
Read MoreSep 14, 2022
TUESDAY, Sept. 13, 2022 (HealthDay News) — The summary Elixhauser (S-Elixhauser) comorbidity...
Read MoreSep 14, 2022
TUESDAY, Sept. 13, 2022 (HealthDay News) — The overall incidence of cutaneous T-cell...
Read MoreSep 14, 2022
TUESDAY, Sept. 13, 2022 (HealthDay News) — The proportion of adolescents and young adults...
Read MoreSep 14, 2022
TUESDAY, Sept. 13, 2022 (HealthDay News) — Potential risk factors for new long-term opioid...
Read MoreSep 14, 2022
TUESDAY, Sept. 13, 2022 (HealthDay News) — President Joe Biden made a renewed push for his...
Read MoreSep 14, 2022
TUESDAY, Sept. 13, 2022 (HealthDay News) — The costs of cancer treatments increased from...
Read MoreSep 12, 2022
For a study, researchers sought to understand the relevant cell lineages, aberrant...
Read MoreSep 12, 2022
Myelosuppressive chemotherapy can cause major infectious problems in individuals with aggressive...
Read MoreSep 12, 2022
For a study, researchers sought to create a pyroptosis-related risk score (RS) model for acute...
Read MoreSep 12, 2022
The standard treatment for relapsed/refractory FLT3-mutated (FLT3mut) acute myeloid leukemia (AML)...
Read MoreSep 12, 2022
Even after an allogeneic hematopoietic stem cell transplant (HCT), outcomes in TP53-mutant (mTP53)...
Read MoreSep 11, 2022
THURSDAY, Sept. 8, 2022 (HealthDay News) — World Trade Center (WTC)-exposed rescue/recovery...
Read MoreSep 11, 2022
THURSDAY, Sept. 8, 2022 (HealthDay News) — Batwing mastopexy can be safely performed at the...
Read MoreSep 11, 2022
FRIDAY, Sept. 9, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Thursday...
Read More